Murdoch Children's Research Institute
Logo
  • Home
  • About
    About Participating sites Consortium members Collaborative Partners Translation Partners
  • Code of ethics
  • Projects
  • Resources
    Resources News Publications
  • Contact

O-SNAP: Optimizing antibiotic dosing in the Staphylococcus aureus Network Adaptive Platform trial

This sub-study aims to find out how much antibiotic we should be giving to adults and children with Staphylococcus aureus blood stream infection (SAB), so that they get the best treatment result.

« Previous project
FosUTI Trial: Optimising the treatment of antibiotic resistant urinary tract infections in children
Next project »
ID-MAGIC: Individualised Dose optiMisAtion of Ganciclovir in Immunocompromised Children Trial
  • Projects
  • BEST Trial: Bone and Joint infection – Simplifying treatment in Children Trial
  • FosUTI Trial: Optimising the treatment of antibiotic resistant urinary tract infections in children
  • O-SNAP: Optimizing antibiotic dosing in the Staphylococcus aureus Network Adaptive Platform trial
  • ID-MAGIC: Individualised Dose optiMisAtion of Ganciclovir in Immunocompromised Children Trial
  • Advancing the evidence base for off-label medications in children
  • Audit of therapeutic drug monitoring of Vancomycin in paediatric tertiary hospitals
  • A pharmacokinetic study of fluoroquinolones using capillary microsampling
  • Future directions – scoping literature review for antimicrobials for drug-resistant bacterial infections in children
Murdoch Children's Research Institute

Ⓒ 2023 Murdoch Children's Research Institute

  • We follow the Australian Privacy Principles
  • General Privacy Policy
  • Terms & Conditions